Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial

By sjmartinez • June 28, 2024

Dehghani P, Srivatsav V, Vardeny O, Grewal J, Opotowsky AR, Muhll IV, Keir M, Ducas R, Singh J, Kim K, Joseph J, Aboulhosn J, Havighurst T, Hegde SM, Bhatt DL, Solomon S, Farkouh M, Goodman SG, Moe TG, Udell JA. Feasibility and Findings of Including Self-Identified Adult Congenital Heart Disease Patients in the INVESTED Trial. JACC Adv. 2024 Mar 14;3(4):100897. doi: 10.1016/j.jacadv.2024.100897. PMID: 38939662; PMCID: PMC11198655.

Tags: adult congenital, Cardiology/Epi, Heart disease, Influenza, Publications, Vaccination

Response by Fonarow et al to Letter Regarding Article, “Improving Heart Failure Quality of are Over the First Twenty Years: The Get With The Guidelines-Heart Failure Program”

Tang AB, Greene SJ, Fonarow GC. Response by Fonarow et al to Letter Regarding Article, "Improving Heart Failure Quality of are Over the First Twenty[...]

Real-World Outcomes of Dedicated Leaflet Modification for Bioprosthetic Valve-In-Valve TAVR: A 150-Patient Commercial Experience

Makkar RR, Gupta A, Inglessis I, Stinis CT, Yadav PK, Thourani VH, Chetcuti SJ, Summers M, Patel V, Chehab BM, Patel A, Tang GHL, Khera[...]

Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry

Lindman BR, Gillam LD, Perpetua EM, Elmariah S, Otto CM, Scherrer-Crosbie M, O'Gara PT, Leon MB, Mack M, Thourani V, Gluckman TJ, Dauerman HL, Tanguturi[...]